Search - tctmd.com

Displaying 201 - 220 of 2299

Sort: Relevancy | Date

Presentation NY Valves 2025

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Presenter: Laura Flannery

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Optimal Implantation Technique

Presenter: Saurabh Sanon

June 25, 2025

Presentation NY Valves 2025

Heart Team Discussion: Importance of PPM

Presenter: Rishi Puri

June 25, 2025

Presentation NY Valves 2025

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

Presenter: Santiago Garcia

June 25, 2025

Presentation NY Valves 2025

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Presenter: Shinichi Fukuhara

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

CT Reduces In-Hospital Complications in SAVR

Presenter: Liliane Zillner

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Presentation NY Valves 2025

Perspectives From TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

June 25, 2025

Presentation NY Valves 2025

Not Much, We Need Stronger Evidence!

Presenter: Michael J. Mack

June 25, 2025

Presentation NY Valves 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

June 25, 2025

Advertisement

Heart Team Discussion: Importance of Preserving Coronary Access after TAVI

Heart Team Discussion: Optimal Implantation Technique

Heart Team Discussion: Importance of PPM

Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position

TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Case Resolution

Can We Solve the Durability Issue? Insights Into New Valve Designs

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

CT Reduces In-Hospital Complications in SAVR

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content